How much does Tarceva (Erlotinib Hydrochloride Tablets) Cost& price without insurance in China?
Tarceva® is the commercial brand name of Erlotinib Hydrochloride Tablets, an orally active reversible EGFR tyrosine kinase inhibitor developed by Roche. It selectively blocks epidermal growth factor receptor kinase to inhibit downstream tumor cell proliferation signaling.
Main Indications
First-line maintenance or second-line treatment for locally advanced or metastatic non-small cell lung cancer in patients with confirmed EGFR sensitive mutations;
Combined with gemcitabine for advanced pancreatic cancer.
Common Side Effects
Common mild adverse reactions: Rash, diarrhea, dry skin, fatigue and anorexia.
Laboratory abnormalities: Transient mild liver enzyme elevation.
Severe but manageable risks: Interstitial lung disease, severe gastrointestinal bleeding and hypersensitivity reactions.
Approval Status in China
Tarceva® (Erlotinib Hydrochloride Tablets, 150mg) was officially approved for marketing in China in 2006. It is currently a prescription anti-tumor drug included in China’s Category B medical insurance.
Buy Tarceva (Erlotinib Hydrochloride Tablets) online from China and save up to 80% on costs . no insurance needed . compare prices from a certified HongKong pharmacy .with fast shipping. Contact us now on WhatsApp to get the latest prices.
